Loading...
Loading...
Morgan Stanley downgraded its rating on Quality Systems
QSII from Equal-weight to Underweight and removed its previous $17 price target.
Morgan Stanley said, "ack of visibility to revenue growth, recent management departure, and uncertainty around ambulatory end market opportunity should cap QSII's multiple in the near-term in our view. …QSII's guidance retraction and recent NextGen president departure add to the uncertainty around management's ability to reaccelerate revenue growth. … We believe QSII will underperform our HCIT as well as our broader healthcare service coverage universe due to its positioning relative to industry and what we view as unfavorable end customer trends."
Quality Systems closed at $18.53 on Friday.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in